See All Slides - tctmd.com

Slides

Presentation

Nonobstructive CAD and Risk of MI

Presenter: Thomas M. Maddox

November 04, 2014

Presentation

Risk of Bleeding With Dabigatran in A-fib

Presenter: I. Hernandez

November 04, 2014

Presentation

TCT Top Late Breaking Trials:TAVR Studies

Presenter: Gregg W. Stone

November 03, 2014

Presentation

Impact of DES on the Comparative Effectiveness of CABG and PCI

Presenter: Mark A. Hlatky

November 03, 2014

Presentation

Culprit-Vessel vs Multivessel Intervention at the Time of Primary PCI in Patients With STEMI and Multivessel Disease

Presenter: M. Bilal Iqbal

November 03, 2014

Presentation

Postprocedural Hemodiafiltration in ACS Patients With Renal and Cardiac Dysfunction Undergoing Urgent, Emergent Coronary Angiography

Presenter: Giancarlo Marenzi

November 02, 2014

Presentation

Bioresorbable Scaffold (BRS) Induces Neointimal Cap That Seals Plaque Without Compromising Lumen Size

Presenter: C.V. Bourantas

November 02, 2014

Presentation

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Presenter: M.K. Lam

October 31, 2014

Presentation

Chronic Vitamin K Antagonist Therapy and Bleeding Risk in STEMI Patients

Presenter: Wassef Karrowni

October 30, 2014

Presentation

Risk Model for Estimating the 1-Year Risk of Intervention Following Deferred Revascularization After FFR Assessment

Presenter: J.P. Depta

October 29, 2014

Advertisement

Slides

Nonobstructive CAD and Risk of MI

Risk of Bleeding With Dabigatran in A-fib

TCT Top Late Breaking Trials:TAVR Studies

Impact of DES on the Comparative Effectiveness of CABG and PCI

Culprit-Vessel vs Multivessel Intervention at the Time of Primary PCI in Patients With STEMI and Multivessel Disease

Postprocedural Hemodiafiltration in ACS Patients With Renal and Cardiac Dysfunction Undergoing Urgent, Emergent Coronary Angiography

Bioresorbable Scaffold (BRS) Induces Neointimal Cap That Seals Plaque Without Compromising Lumen Size

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Chronic Vitamin K Antagonist Therapy and Bleeding Risk in STEMI Patients

Risk Model for Estimating the 1-Year Risk of Intervention Following Deferred Revascularization After FFR Assessment

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content